Abstract
Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy analysis of 6-substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester derivatives
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have